About
Technology
Issues
FAQ
Links
Official Page
400P Impact of regorafenib dose optimization on comparative outcomes in the treatment of relapsed/refractory metastatic colorectal cancer (mCRC)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.